CRKL and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast, imatinib failed to induce apoptosis in CML iCD34+ cells (Fig. 3fi), despite the abrogation of p-CRKL signaling in these cells (Fig. 3c and d).